Proportion of patients in each NAS sub-score category at baseline and week 48 (paired biopsy evaluation).
NAFLD
NON-ALCOHOLIC FATTY LIVER DISEASE
M, the total number of subjects with a value for a specific categorical variable; n, number of subjects who are at the corresponding category; N, the total number of subjects in the treatment group; NAFLD, non-alcoholic fatty liver disease; NAS, NAFLD activity score; TXR, tropifexor.
